CATALYST BIOSCIENCES, INC. Business Finance Contracts & Agreements

56 Contracts & Agreements

Browse by Subcategory

Equity Distribution Agreements (1 contract)
Escrow Agreements (1)
Exchange Agreements (1)
Indenture Agreements (1)
Investor Rights Agreements (2)
Loan Agreements (3)
Note Agreements (4)
Purchase Agreements (9)
Share Agreements (1)
Stock Agreements (12)
Underwriting Agreements (8)
Waiver Agreements (6)
Warrant Agreements (7)

Recent Contracts

Securities Purchase Agreement, dated October 27, 2023, by and between Catalyst and GNI USA (Filed With SEC on October 30, 2023)
Form of Warrant to Purchase Series X Convertible Preferred Stock (Filed With SEC on October 30, 2023)
Waiver Agreement between Catalyst Biosciences, Inc. and Ms. Seline Miller, dated January 17, 2023 (Filed With SEC on August 14, 2023)
Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Grant Blouse, dated January 14, 2023 (Filed With SEC on August 14, 2023)
Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Nassim Usman, dated January 17, 2023 (Filed With SEC on August 14, 2023)
Waiver Agreement between Catalyst Biosciences, Inc. and Ms. Seline Miller, dated January 17, 2023 (Filed With SEC on May 15, 2023)
Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Grant Blouse, dated January 14, 2023 (Filed With SEC on May 15, 2023)
Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Nassim Usman, dated January 17, 2023 (Filed With SEC on May 15, 2023)
Contingent Value Rights Agreement, dated as of December 26, 2022, between Catalyst and American Stock Transfer & Trust Company, LLC (Filed With SEC on May 15, 2023)
Agreement and Amendment to Asset Purchase Agreement, dated as of March 29, 2023, by and among Catalyst, GNI Group and GNI HK (Filed With SEC on March 30, 2023)
Asset Purchase Agreement dated as of February 27, 2023 by and between Catalyst Biosciences, Inc. and GC Biopharma Corp (Filed With SEC on March 2, 2023)
Asset Purchase Agreement, dated December 26, 2022, by and among Catalyst Biosciences, Inc., GNI Group Ltd., and GNI Hong Kong Limited (Filed With SEC on December 27, 2022)
Form of Stock Option Award Agreement (Filed With SEC on March 31, 2022)
Equity Distribution Agreement, dated as of October 15, 2021, between Catalyst Biosciences, Inc. and Piper Sandler & Co (Filed With SEC on October 15, 2021)
Form of Stock Option Award Agreement (Filed With SEC on March 4, 2021)
Underwriting Agreement, dated January 26, 2021, by and between Catalyst Biosciences, Inc. and Piper Sandler & Co., as representative of the several Underwriters named therein (Filed With SEC on January 27, 2021)
Underwriting Agreement, dated June 18, 2020, by and between Catalyst Biosciences, Inc. and Raymond James & Associates, Inc., as representative of the several Underwriters named... (Filed With SEC on June 19, 2020)
Underwriting Agreement, dated February 13, 2020, by and between Catalyst Biosciences, Inc. and Raymond James & Associates, Inc., as representative of the several Underwriters... (Filed With SEC on February 14, 2020)
Underwriting Agreement, dated February 13, 2018, by and between the Company and JonesTrading Institutional Services LLC as representative for the several underwriters named therein (Filed With SEC on February 15, 2018)
Underwriting Agreement, dated December 20, 2017, by and between the Company and JonesTrading Institutional Services LLC as representative for the several underwriters named therein (Filed With SEC on December 22, 2017)
CATALYST BIOSCIENCES, INC. (Formerly, Targacept, Inc.) 2015 STOCK INCENTIVE PLAN Incentive Stock Option Agreement (Employees) (Filed With SEC on July 14, 2017)
930,000 SHARES OF COMMON STOCK, 13,350 SHARES OF SERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO 2,670,000 SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLE INTO 1,800,000... (Filed With SEC on April 13, 2017)
COMMON STOCKPURCHASE WARRANT CATALYST BIOSCIENCES, INC. (Filed With SEC on April 4, 2017)
SHARES OF COMMONSTOCK, SHARES OF SERIES ACONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLEINTO SHARES OF COMMON STOCK) OF CATALYST... (Filed With SEC on April 4, 2017)
WARRANT TO PURCHASE STOCK OF CATALYSTBIOSCIENCES, INC. (Filed With SEC on March 9, 2016)
WARRANT TO PURCHASE STOCK OF CATALYST BIOSCIENCES, INC. (Filed With SEC on March 9, 2016)
WARRANT TO PURCHASE STOCK (Filed With SEC on March 9, 2016)
ESCROW AGREEMENT (Filed With SEC on September 4, 2015)
TARGACEPT, INC., asIssuer, and AMERICANSTOCK TRANSFER & TRUST COMPANY, LLC, Trustee Indenture Dated as ofAugust 19, 2015 Providing for the Issuance Of Redeemable Convertible... (Filed With SEC on September 4, 2015)
CATALYST BIOSCIENCES, INC. STOCK OPTION AGREEMENT EARLY EXERCISE (Filed With SEC on May 22, 2015)
CATALYST BIOSCIENCES, INC. STOCK OPTION AGREEMENT EARLY EXERCISE (Filed With SEC on May 22, 2015)
CATALYST BIOSCIENCES, INC. STOCK OPTION AGREEMENT EARLY EXERCISE (Filed With SEC on May 22, 2015)
CATALYST BIOSCIENCES, INC. 2004 STOCK PLAN (Filed With SEC on May 22, 2015)
CERTAIN CONFIDENTIAL MATERIAL APPEARING IN THIS DOCUMENT, MARKED BY [********], HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE... (Filed With SEC on March 14, 2014)
TARGACEPT, INC. CommonStock (par value $0.001 per share) At-the-Market Issuance Sales Agreement (Filed With SEC on November 26, 2013)
Targacept, Inc. Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on May 20, 2011)
ASSET PURCHASE AND TRADEMARK ASSIGNMENT AGREEMENT (Filed With SEC on March 14, 2008)
LOAN AGREEMENT (Filed With SEC on March 12, 2008)
3,800,000 Shares Targacept, Inc. Common Stock ($0.001 Par Value) (Filed With SEC on January 18, 2008)
STOCK PURCHASE AGREEMENT BY AND BETWEEN TARGACEPT, INC. AND GLAXO GROUP LIMITED DATED AS OF JULY 27, 2007 STOCK PURCHASE AGREEMENT (Filed With SEC on November 9, 2007)